{
    "clinical_study": {
        "@rank": "122752", 
        "arm_group": [
            {
                "arm_group_label": "Infant starter formula", 
                "arm_group_type": "Active Comparator", 
                "description": "standard infant formula"
            }, 
            {
                "arm_group_label": "Infant starter formula + prebiotics + probiotics", 
                "arm_group_type": "Experimental", 
                "description": "infant formula"
            }, 
            {
                "arm_group_label": "Breastfeeding group", 
                "arm_group_type": "Other", 
                "description": "reference group"
            }
        ], 
        "brief_summary": {
            "textblock": "The clinical trial  aims at showing efficacy of prebiotics and the probiotic  on microbiota\n      balance. Together, the prebiotic solution in combination with the probiotic is expected to\n      harmonize the microbiota of formula fed neonates with the microbiota of breast fed neonates\n      and to allow a greater diversity of Bifidobacteria species in comparison with a formula\n      non-supplemented with pre and probiotics."
        }, 
        "brief_title": "Symbiotic & Colonization", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "detailed_description": {
            "textblock": "The infants will be recruited and randomized between 0 and 14 days. The intervention period,\n      in terms of data necessary for the primary outcome, will be until they reach 3 months old.\n      Measurements will be collected on three separate occasions during this period, i.e. 2 and 6\n      weeks and 3 months. Stools will be collected, on 3 separate occasions, i.e. 4-5 day, 6 weeks\n      and 3 months of life."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy newborn infant\n\n          -  Full term infant (\u2265 37 weeks gestation; \u2264 42 weeks gestation)\n\n          -  Age of infant is between 14 days at the time of enrollment\n\n          -  Birth weight between 2500g and 4500g\n\n          -  For the Formula fed groups: The infant's mother has elected, before the 14th day of\n             their child's life, not to continue breastfeeding (no breastfeeding after the 14th\n             day of the child's life) For the Breastfed group: The infant's mother has elected to\n             fully breastfeed her baby, from enrollment to at least 3 months of age\n\n          -  Having obtained his/her legal representative's informed consent\n\n        Exclusion Criteria:\n\n          -  Congenital illness or malformation that may affect normal growth\n\n          -  Significant pre-natal and/or post-natal disease\n\n          -  Re-hospitalization for more than 2 days in the first 14 days of life.\n             (Exceptionally, infants re-hospitalized because of jaundice may be enrolled in the\n             study).\n\n          -  Newborn who have received antibiotics during the first 14 days of life\n\n          -  Receiving infant formula containing pro and/or prebiotics at the time of enrolment\n\n          -  Newborn whose parents / caregivers cannot be expected to comply with treatment\n\n          -  Newborn currently participating in another clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "4 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "141", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983072", 
            "org_study_id": "06.08.INF"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Infant starter formula", 
                    "Infant starter formula + prebiotics + probiotics"
                ], 
                "intervention_name": "Infant formula", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Breastfeeding group", 
                "description": "Breastfeeding", 
                "intervention_name": "Breastfeeding", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "colonization of the gastrointestinal tract with bacteria", 
        "lastchanged_date": "November 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13015"
                    }, 
                    "name": "H\u00f4pital de la Conception"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13008"
                    }, 
                    "name": "H\u00f4pital Saint Joseph"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13015"
                    }, 
                    "name": "H\u00f4pital Nord"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "01-184"
                    }, 
                    "name": "The Medical University of Warsaw"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Poland"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Starter Formula With Symbiotic on Microbiota Balance", 
        "overall_official": {
            "affiliation": "The Medical University of Warsaw", 
            "last_name": "Hania Szajewska", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Poland: Ethics Committee", 
                "France: Ethics committee, AFSSAPS"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "(Lactobacilli, Clostridia, Bacteroides, bifidobacteria, staphylococci, Enterobacteria and Bifidobacterial species at 1.5 months and 3 months of age of the infants.", 
            "measure": "stool bacterial populations", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983072"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "weight", 
                "measure": "changes in weight", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)", 
                "measure": "Digestive tolerance (stool characteristics and frequency, vomiting, regurgitation, frequency of colic)", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "changes in length", 
                "measure": "changes in length", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}